4/A
Changes in Ownership
Relay Therapeutics, Inc. Filed Acc 0001209191-21-039322
Senior Vice President, Finance sold 22,500 shares at $35.00 ($787,500)
- Senior Vice President, Finance acquired 22,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Catinazzo Thomas · Senior Vice President, Finance
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-03-30 | Exercise or conversion : show line 1 in the form | +22,500 | $4.12 | $92,700 | 38,370 | D |
| 2021-03-30 | Sale : show line 2 in the form | −22,500 | $35.00 | $787,500 | 15,870 | D |
| Open-market sales · 22,500 sh · avg $35.00 · $787,500 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-03-30 | Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) | −22,500 | 107,043 | D |
Loading xslF345X03/doc4a.xml…